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Abstract
Background: In cases of lead failure after implantation of pacemakers (PM) or implantable cardioverter defibrillators
(ICD) early lead replacement may be challenging. Puncture of the subclavian vein bears possible complications such
as pneumothorax, hematothorax, and damage of leads to be left in place. To avoid venous puncture PM or ICD
leads were replaced using a flexible polypropylene sheath (Byrd-sheath).
Method: From January 2010 through December 2017, 55 patients underwent early lead exchange avoiding venous
puncture. Early lead exchange for this study was defined as a reintervention within 14 days after the initial lead
implantation. The connector of the malfunctioning lead was cut off, and stabilized by a stiff stylet. After having cut
off the plastic knob of the stylet, the lead was passed through the polypropylene sheath and the latter advanced
into the subclavian vein with gentle rotational movements to gain access to the subclavian vein. After lead removal
the polypropylene sheath was replaced by a peel away sheath a new lead inserted.
Results: Overall, 23 defibrillation leads and 34 pacing leads (16 right atrial leads, 17 right ventricular leads, and 1 left
ventricular lead) were successfully explanted. Access to the subclavian vein was uneventful, and blood loss minimal.
Radiation exposure and fluoroscopy time were also negligible.
Conclusion: The Byrd-sheath technique proved to be safe and successful in providing vein access within 2 weeks
after initial lead implantation using the previously implanted lead and thus avoiding puncture of the subclavian vein.
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Background
Malfunction or dislodgement of pacemaker (PM) or im-
plantable defibrillator/cardioverter (ICD) leads should be
corrected as they may result in significant morbidity.
However, lead replacement procedures may pose certain
risks after implantation of PMs or ICDs. Access to the
subclavian vein may cause bleeding at the puncture site,
as well as a hematothorax or pneumothorax especially in
patients with chronic obstructive pulmonary disease,
frailty, or cachexia [1–4]. Furthermore, the leads
remaining can be damaged. Anticoagulants or platelet in-
hibitors increase the risk of bleeding complications with
accidental puncture of the adjacent subclavian artery [4].
The manuscript presents results using a modified pre-
viously described method of exchanging pacemaker or
defibrillator/cardioverter leads maintaining the venous
access, and eliminating the need of venous puncture
(Byrd-sheath technique) [5, 6].
Method
From January 2010 to December 2017, 55 patients
underwent early lead exchange avoiding venous punc-
ture. Early lead exchange for this study was defined as
reintervention up to 14 days after the initial lead im-
plantation. All data had been prospectively collected in
the institutional database.
Patient data
Demographic data included age, gender, underlying dis-
eases, and anticoagulation as well as the necessary
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information with regard to the initial implantation pro-
cedure. Procedural data contained time of procedure,
time to gain access to the attempted vein, sheaths used,
and fluoroscopy time. The procedural success and blood
loss during the procedure were documented as well as
postoperative pocket hematoma and infection.
Surgical procedure
After having opened the generator pocket any sutures
were removed from the lead to be replaced. Any other
sutures (e.g. ligature of the cephalic vein) compromising
the lead were also removed. Active fixations of leads
were loosened. The connector of the lead was cut off
and the suture sleeve removed. The lead was stabilized
by a standard stiff stylet which was usually provided
along with the new lead. The stiff stylet provided enough
stiffness to allow advancement of a sheath over the lead.
After the plastic knob of the stylet had been cut off, the
insulation of the lead was fixed with a suture long
enough to pass a flexible polypropylene sheath (Fig. 1).
A polypropylene sheath of the size just to slide over the
lead was chosen (Byrd Dilator Sheath Polypropylene,
Cook Medical, Cook Inc., Bloomington, IN, USA). The
sheath was gently advanced towards the subclavian vein
with rotational movements using fluoroscopic control
and assuring a gentle longitudinal movement without
dislodging or distorting of the lead (Fig. 2). As soon as
access to the vein was gained, the lead was removed. Ac-
cess to the vein was indicated by dripping of blood from
the polypropylene sheath (Fig. 3). Attention was drawn
not to advance the sheath any further. A j-tipped guide
wire was placed through the polypropylene sheath and a
hemostatic peel-away introducer carefully advanced into
the vein (SafeSheath®, Pressure Products Medical
Supplies, Inc., Santa Barbara, USA or Prelude SNAP
splittable sheath introducer, Merit Medical Systems Inc.,
Malvern, PA, USA).
Statistical analysis
Statistical analysis was performed with Stata 10.1 SE for
Windows (StataCorp., College Station, TX, USA).
Continuous data were first tested for normality with the
Shapiro–Wilk test. If normally distributed, these data are
presented as means ± SD. Dichotomous data are
expressed as numbers and percentages. The Mann–Whit-
ney Rank sum test was used for non-normally distributed
data. The tests were performed two-sided, and a p-value
of < 0.05 was considered to be statistically significant.
Fig. 1 Preparation of the lead to be exchanged. Stiff stylet in lead to
be exchanged, lead insulation fixed with suture (note ICD-lead being
left in place)
Fig. 2 Radiofluoroscopy. Radioflouroscopic image of Byrd-sheath
having been advanced over the lead (note the artrial lead had been
loosened from active fixation for removal purose, the ICD lead
remaining in place)
Fig. 3 Access to vein. Byrd-sheath in subclavian vein (note blood
dripping from sheath)
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Results
Over a period of 8 years, 1946 patients with cardiac im-
plantation of electrical devices were treated, thereof 525 re-
vision procedures including all lead replacements. We
detected 55 patients (35 male, 18 female) with early lead
malfunction. Mean patient age was 67 ± 11 years (range 36
through 94 years). Twenty-four patients had a Phenprocu-
mon or duel / triple platelet inhibition medication therapy.
Overall, 57 leads had to be replaced. Lead replacement
was performed in 25 pacemaker systems (5 VVI, 20
DDD), and 30 ICD systems (14 VVI ICD, 10 DDD ICD, 6
CRT-D). Fifteen patients were referred to our institution
for early lead exchange from other hospitals (27%). The
indications for replacement were dislocation (n = 21),
insufficient threshold (n = 22), and over−/undersensing
(n = 14). Accordingly, 23 defibrillation leads, 16 right atrial
leads, 17 right ventricular pace-sense leads, and 1 left ven-
tricular lead had to be replaced. The mean dwell time of
the leads after implantation was 3.6 ± 3.4 days (range 0
through 12 days). During the procedures, 40 leads in 34
patients remained in place. In 45 patients, the pacemaker
or ICD was on the left side (82%), whereas 10 patients had
a right-sided implantation (18%). A primary access via the
cephalic vein was present in 15 patients (27%).
All procedures were successful. Mean time to gain access
to the venous system was 2 ± 1 min. Blood loss was negli-
gible in all cases. X-ray burden of the entire reintervention
varied from 75.7 cGy*cm2 through 6740.7 cGy*cm2 (mean
1021.2 ± 1095.65 cGy*cm2) with time of fluoroscopy ran-
ging from 0.24 min to 15.4 min (mean 3.28 ± 3.02 min). No
postoperative pocket hematoma or infection developed.
There were neither major nor minor complications.
We could not find a significant difference between patients
with pacemaker or implantable cardioverter-defibrillator
concerning the body mass index or age (p= 0.165; p= 0.479
respectively). Mean of ejection fraction was better in pace-
maker patients compared to ICD patients (p= < 0.001).
However, there was no difference when comparing
pacemaker and ICD patients with respect to access
time (p = 0.392), procedural time (p = 0.375), X-ray time
(p = 0.819) and X-ray burden (p = 0.642).
Significant differences were also not found when com-
paring male with female patients with respect to ejection
fraction (p = 0.189), as well as access and procedure time
(p = 0.757; p = 0.785 respectively). Female patients
though had a significant higher X-ray time (p = 0.026),
but the X-ray burden appeared to be comparable and
lacked statistical significance (p = 0.111).
An immediate lead exchange during the initial im-
plant procedure occurred in 11 of the 55 patients.
The procedure time was significantly higher in these
patients (p = < 0.001). Likewise, the X-ray time and
X-ray burden were significantly higher (p= < 0.001; p= 0.003
respectively).
Discussion
Since Furman and Chardack introduced the first im-
plantable pacemakers in the 1960s [7], the venous access
has been improved by King [8] and Belott [9]. With in-
creasing numbers of pacemakers and implantable cardi-
overter/defibrillators the quantity of lead malfunction
steadily rises, and lead replacement remains a necessity
and a challenge.
Puncture of the subclavian vein is common to gain ac-
cess to the venous system in order replace malfunction-
ing leads. Complications associated with venous
puncture are well described. Pneumothorax and hema-
tothorax as major complications are rather infrequent,
the incidence is described in 0.1–1.3% [1, 4]. Bleeding at
the puncture pocket site as minor complication occurs
in up to 2% [10, 11]. Most of the pocket hematomas are
related to pocket formation rather than back from the
venous system. Further, collateral lead damage is pos-
sible to other leads. This is exceedingly rare, though.
Major complications such as perforation of central
veins and cardiac cavities have been described in causal
connection with lead extraction or replacement [12].
Minor complications, such as pericardial effusion not re-
quiring pericardiocentisis or surgical intervention, and
hematothorax not requiring a chest tube, are linked to
lead extraction [12]. Arm swelling or thrombosis of im-
plant veins resulting in medical intervention, hematoma
at the surgical site requiring reoperation for drainage,
vascular repair near the implant site or venous entry site,
blood transfusion related to blood loss during surgery,
and pulmonary embolism not requiring surgical inter-
vention are further adverse events classified as minor
complications [12].
Using polypropylene sheaths to gain access to the ven-
ous system also bears the risk of bleeding, too, as the
outer diameter is significantly larger than the lead body
itself. Thorough surgery may well prevent bleeding back
from the venous system even if a polypropylene sheath
with is used. Sliding a properly sized peel-away intro-
ducer over the lead after it has been stabilized with a
stiff stylet does not achieve the same results. The stiff
stylet and the proximal end of the lead will have to be
brought forward through the introducer cap in a retro-
grade manner. Especially when gaining the access to the
subclavian vein, the rather soft tip of the peel-away
introducer tends to be damaged by surrounding tissue.
The damaged tip of the peel-away introducer may in-
hibit further advancement or even serious injury to the
wall of the subclavian vein.
According to the analysis of Sant’Anna et al. we as-
sume the proposed procedure safer, as we observed no
bleeding complication with respect to our patients, as
half of them were treated with oral anticoagulation or
dual / triple platelet inhibition [13]. Neither bleeding
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from the puncture site nor bleeding as result of puncture
of the axillary artery occurs when lead exchange is per-
formed avoiding puncture techniques.
Air embolism is a rare but possible complication when
using the polypropylene sheath technique. This complica-
tion did not occur and is avoided by keeping the patient in
a slight Trendelenburg position during the procedure.
For primary venous access a retained guide wire tech-
nique is described by Byrd [14]. It may be helpful as a
back-up method to avoid a second venous puncture in
cases when the lead planted first has to be exchanged
[15]. The guide wire is left in place in the sheath after
the dilator is withdrawn, thus allowing the introduction
of a second sheath to pass through a new pacing lead.
However, this technique requires a larger intruding
sheath and can be utilized only during the same implant-
ation procedure when the first implanted lead is prob-
lematic. The guide wire itself may interfere with the lead
placement. Having placed two guide wires with one
introducer and using separate introducers for lead place-
ment does not solve the interference and friction of mul-
tiple leads. In any case, these techniques may only be
considered for primary implantation procedures.
A wire under the insulation technique to maintain ven-
ous access for the purpose of lead exchange has been pre-
viously described by Steinberg [16]. This technique may
be employed in redo procedures. Yet, lead-on-lead inter-
action may render this approach challenging having two
leads in place. Lead-on-lead interaction especially applies
to silicone insulation layers. Even if the lead can be easily
moved from the endocardium to the superior vena cava
using direct traction, dislocation of the wire is possible
with advancement of the lead. As the Byrd-technique indi-
cates venous access as soon as blood is dripping out of the
sheath, no further advancement of the sheath is required,
thus simplifying he process. After the j-tipped guide-wire
has been advanced, the access is secured. Once the access
is assured, the situation will equal a normal lead
implantation.
Leads with efficient passive fixation leads may be diffi-
cult to remove 4–6 months after implantation [14]. Fi-
brotic attachments develop between chronically implanted
leads and venous, valvular and cardiac structures may
pose obstacles to successful lead extraction [15]. The same
applies to active fixation, as the fixation mechanism, the
screw, may not be readily loosened. The reported tech-
nique is a modification of the described methods of Byrd
and Bongiorni which allows overcoming these obstacles
and may easily be used during or early after lead implant-
ation, sacrificing the original lead(s) [5, 17].
This method may be employed within 1 year whenever
lead malfunction occurs [14]. We focussed on early lead
exchange ranging from intraoperatively to a maximum of
14 days since the initial implantation to eliminate
adhesions possibly occurring within the first year of im-
plant. The indication to sacrifice a lead with early mal-
function is seen in bits of myocardium and/or small
thrombi compromising the fixation mechanism. This ap-
plies to both active and passive fixation mechanisms of
leads. Both fixation mechanisms may be impaired and un-
satisfactory for proper and safe repositioning of a lead.
We could exchange all leads intended to be replaced
leaving additional leads in place. Virtually any leads
could be replaced, and any lead could be left in place
without dislocation. It seems obvious, that obligate intra-
operative lead exchanges proof to have the highest X-ray
doses due to the difficulties in achieving a sufficient
threshold and/or sensing during lead placement. As only
a few seconds of additional time of fluoroscopy are re-
quired to gain access to the vein the additional X-ray
burden remains negligible, especially when considering
the entire procedural X-ray doses of lead exchanges [18].
None of the patients experienced complications due to
the redo procedure.
As the implanted pacemaker devices are located in a
layer under the pectoral fascia, the procedure of pace-
maker lead replacement is well performed in local anaes-
thesia. We generally implant ICD devices in a sub
muscular layer and accordingly approached defibrillator
lead replacement in general anaesthesia, which is not
mandatory. In any case, the technique of using a sheath
for lead replacement itself does not oblige to a certain
form of anaesthesia.
Limitation
Our study has several limitations. It was designed as a
retrospective study and conducted at one single medical
centre. The number of reinterventions and referred pa-
tients for early lead exchange appears to be rather high.
We interpret the referral of complex patients as a part
of the duties of a department of cardiothoracic surgery.
The study does not compare venous puncture with the
described approach; there may be a selection bias. Ex-
perience in lead extraction may be of advantage.
Conclusion
The technique of lead replacement using a flexible poly-
propylene sheath (Byrd-sheath) proved to be safe and suc-
cessful in providing venous access using the previously
implanted lead and thus avoiding puncture of a vein. The
technique is simple and can be performed with standard
operating room instruments. When clinically indicated,
we advocate our method of replacing pacemaker or defib-
rillator/cardioverter leads in order to facilitate the proced-
ure and minimize intraoperative complications.
Abbreviations
CRT-D: cardiac resynchronization therapy defibrillator cardioverter; DDD
ICD: duel chamber implantable cardioverter defibrillator; DDD: duel chamber
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pacemaker; ICD: implantable defibrillator cardioverter; PM: Pacemaker; VVI
ICD: single chamber implantable cardioverter defibrillator; VVI: single
chamber pacemaker
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